Introduction
============

*M*alaria is the most important vector-borne infectious disease ([@B1]). Globally, 3.4 billion people are at risk of being infected with malaria. According to the latest report of the WHO, 212 million cases were reported from 91 countries and territories with 429,000 deaths in 2015 ([@B2]).

Blood transfusion is one of the potential routes of malaria transmission ([@B3]). Woolsey reported the first case of transfusion-transmitted malaria (TTM) in 1911 ([@B4]). "The occurrence of TTM in non-endemic and endemic areas of malaria is one case per four million and more than 50 cases per million units of transfused blood and blood components, respectively ([@B5]--[@B9])". More than 3,000 cases of TTM were reported in the world ([@B10]). The transmission of malaria via blood transfusion is a serious risk in non-immune recipients to malaria, especially if the parasite species is *Plasmodium falciparum* ([@B5], [@B11]--[@B16]), as the diagnosis of malaria is often missed in the recipient ([@B11]).

Malaria screening is performed in blood donors by various strategies including donor selection or screening of blood donors through interviewing, and laboratory tests ([@B12]). Since there is no reliable approved laboratory test yet available for malaria screening in blood donors ([@B17]), "the donor selection is the first, and in many countries, the only step in the prevention of TTM ([@B18])". In this strategy, the potential donors with a history of malaria or travel to, or residence in, malarious areas are deferred from donating blood permanently or for a certain period of time ([@B19]). These deferrals may affect the blood availability ([@B20]), although most deferred people are unlikely to be infected particularly travelers to malaria-endemic areas ([@B12], [@B19], [@B21]). The deferral rate of blood donation volunteers due to malaria risk has been reported to vary from 0.003% to 5% in different countries ([@B9]).

In 1974, the Iranian Blood Transfusion Organization (IBTO) was established in order to centralize blood and blood components supply ([@B22], [@B23]). The IBTO is a non-profit and national organization that currently has 31 provincial blood transfusion centers. The screening of blood donors for malaria, in endemic and non-endemic regions of Iran, is performed in the blood transfusion centers of the IBTO through interviewing by a trained physician ([@B22]--[@B24]). Based on the IBTO standard operating procedures (SOPs), volunteers who have a history of malaria are permanently deferred from blood donation. A history of travel to, or residence in, malarious areas lead to a deferral from donating blood for three years after departure and one year after their return from the endemic area, respectively. According to these instructions, the temporarily malaria-deferred volunteers after the deferral period can donate blood if they have not experienced malaria symptoms. Unfortunately, these volunteers are not investigated using laboratory (parasitological, immunological and molecular) assays.

The rate of deferred blood donation volunteers due to malaria risk has not previously been investigated in Iran and the current research is the first study conducted, to the best of our knowledge. Thus, the objective of the present study was to evaluate the blood donor deferrals for malaria in Iran.

Materials and Methods
=====================

Study area
----------

Iran is located in the Eastern Mediterranean Region (EMR) of the WHO ([@B2]) and is subdivided into 31 provinces ([Fig. 1](#F1){ref-type="fig"}). In Iran, malaria transmission mainly occurs in the provinces of the southeast as endemic areas with low endemicity, namely Sistan and Baluchistan, Hormozgan and Kerman ([Fig. 1](#F1){ref-type="fig"}) ([@B25], [@B26]). According to the latest report of the WHO, the reported malaria cases were 1,378 in Iran during the year *2015*, of which 632 (45.86%) were imported cases. Currently, Iran is in the elimination stage of malaria ([@B2]). Although 344 cases of TTM had been reported from different provinces of Iran during the 21 years from 1963 to 1983, no case has been reported in the last three decades ([@B10]).

![Map of 31 provinces of Iran and geographical situation of malaria endemic areas of this country namely Sistan and Baluchestan, Hormozgan and Kerman provinces, bordering Afghanistan, Pakistan, the Oman Sea and the Persian Gulf](IJPA-14-326-g001){#F1}

Data collection and statistical analysis
----------------------------------------

In this retrospective, descriptive cross-sectional study, the comprehensive database of the IBTO, namely Negareh, was used to collect and extract the data of blood donation volunteers who presented to the blood transfusion centers of the IBTO from 21 Mar 2011 to 19 Mar 2016 (5-year period). In the IBTO, the individual characteristics and interview data, as well as the results of screening tests of blood donation volunteers are entered into the Negareh software. Therefore, this software is the best and most reliable way to access, collect and extract data of blood donors. The following data were collected and extracted from the Negareh database: total number of blood donation volunteers (the individuals who presented to the blood transfusion centers for blood donation), blood donors and deferred volunteers, as well as the total number of deferred volunteers for travelling to, or residency in, malarious areas and deferred volunteers for a past history of malaria and the blood donation volunteers' age and sex. Finally, the extracted data were recorded in a structured template form prepared for this purpose. Statistical analysis was conducted using SPSS ver. 18.0 (Chicago, IL, USA).

Results
=======

During the 5-year study period, 12,790,859 blood donation volunteers were presented to the blood transfusion centers of the IBTO and 10,167,915 (79.49%) individuals successfully donated a unit of blood. Among the blood donors, 9,677,820 (95.18%) were male and 490,095 (4.82%) were female with M/F ratio 19.75:1. Of the 2,525,283 (19.74%) deferred blood donation volunteers, 23,084 (0.91%) were deferred for malaria risk. The majority of them (91.11%) were deferred because of travel to and residence in a malaria endemic area, and the remaining 2,053 (8.89%) due to a previous history of malaria. The overall rate of deferred volunteers for malaria was 0.18%. The highest malaria-deferral rate was seen in South Khorasan (0.82%), Razavi Khorasan (0.79%) and Yazd (0.54%) provinces. In contrast, the lowest malaria-deferral rate was in Ilam (0%), Ardabil (0.001%) and Kermanshah (0.002%) provinces ([Table 1](#T1){ref-type="table"}).

###### 

Rates of blood donation and malaria-deferrals in Iran during the 5-year study period (21 Mar 2011 to 19 Mar 2016)

  ***Province***               ***Blood donation volunteers^[\*](#TFN1){ref-type="table-fn"}^, n***   ***Deferred volunteers, n***   ***Blood donors, n***   ***Malaria-deferral type***           
  ---------------------------- ---------------------------------------------------------------------- ------------------------------ ----------------------- ----------------------------- ------- ---------------
  Alborz                       359,760                                                                98,430                         261,330                 152                           8       160 (0.04)
  Ardabil                      192,144                                                                31,397                         157,735                 3                             0       3 (0.001)
  Bushehr                      226,631                                                                55,045                         171,587                 653                           0       653 (0.29)
  Chaharmahal and Bakhtiari    162,072                                                                33,203                         128,869                 225                           7       232 (0.14)
  East Azerbaijan              526,594                                                                85,204                         433,813                 116                           11      127 (0.02)
  Fars                         1,033,563                                                              292,062                        741,501                 3,118                         224     3,342 (0.32)
  Gilan                        436,367                                                                57,458                         377,503                 106                           0       106 (0.02)
  Golestan                     279,139                                                                44,416                         234,723                 510                           0       510 (0.18)
  Hamadan                      234,147                                                                43,816                         190,331                 281                           1       282 (0.12)
  Hormozgan                    266,129                                                                47,020                         219,109                 79                            56      135 (0.05)
  Ilam                         90,099                                                                 16,238                         72,705                  0                             0       0 (0)
  Isfahan                      800,237                                                                172,291                        617,842                 2,225                         39      2,264 (0.28)
  Kerman                       468,564                                                                86,594                         372,862                 661                           140     801 (0.17)
  Kermanshah                   315,989                                                                52,052                         255,912                 5                             2       7 (0.002)
  Khuzestan                    783,718                                                                221,203                        559,015                 570                           75      645 (0.08)
  Kohgiluyeh and Boyer-Ahmad   134,615                                                                19,429                         113,678                 9                             0       9 (0.006)
  Kurdistan                    153,630                                                                22,172                         124,961                 12                            0       12 (0.007)
  Lorestan                     241,457                                                                47,572                         193,985                 5                             22      27 (0.01)
  Markazi                      252,978                                                                48,119                         203,882                 462                           17      479 (0.19)
  Mazandaran                   777,367                                                                124,058                        637,948                 627                           14      641 (0.08)
  North Khorasan               111,855                                                                19,101                         89,643                  71                            0       71 (0.06)
  Qazvin                       196,870                                                                51,472                         145,402                 439                           1       440 (0.22)
  Qom                          225,366                                                                42,205                         183,161                 60                            7       67 (0.03)
  Razavi Khorasan              901,440                                                                236,698                        664,742                 7,159                         1       7,160 (0.79)
  Semnan                       215,278                                                                31,671                         172,802                 308                           3       311 (0.14)
  Sistan and Baluchestan       417,842                                                                68,261                         347,586                 497                           1,381   1,878 (0.45)
  South Khorasan               109,148                                                                19,995                         75,544                  883                           16      899 (0.82)
  Tehran                       2,064,411                                                              304,469                        1,759,942               245                           16      261 (0.01)
  West Azerbaijan              418,593                                                                75,810                         342,782                 85                            3       88 (0.02)
  Yazd                         255,380                                                                52,740                         202,640                 1,370                         8       1,378 (0.54)
  Zanjan                       139,476                                                                25,082                         114,380                 95                            1       96 (0.07)
  Total (%)                    12,790,859                                                             2,525,283 (19.74)              10,167,915 (79.49)      21,031                        2,053   23,084 (0.18)

The individuals who presented to the blood transfusion centers for blood donation

The trend of malaria-deferred blood donation volunteers was not shown as an ascending or descending pattern over the study period.

The average age of the malaria-deferred volunteers was 34 (range 22--58) yr. Of those, 4,135 (17.91%) were in age group 25 yr or less, 15,503 (67.16%) were in group 26--45 yr, and 3,446 (14.93%) were in age group 46 yr or more. Among the malaria-deferred volunteers, 22,139 (95.91%) were male and 945 (4.09%) were female; 2,053 (8.89%) were permanently deferred, while 21,031 (91.11%) were temporarily deferred ([Table 1](#T1){ref-type="table"}). Of the 2,053 permanently malaria-deferred volunteers, 1,759 (85.68%) were male and 294 (14.32%) was female; 1,041 (50.71%), 635 (30.93%) and 377 (18.36%) were in age group 25 yr or less, 26--45 yr and 46 yr or more, respectively.

Discussion
==========

The main purpose of the blood transfusion centers is the supply of safe and adequate blood, and blood components for patients in need. Therefore, all blood donations are screened for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis ([@B27]). Several transfusion-transmitted infections (TTIs), such as malaria, babesiosis, leishmaniasis and American trypanosomiasis (Chagas disease), are not laboratory screened, and donor selection or screening of blood donors through interviewing is the only way of prevention ([@B27], [@B28]).

In Iran and most malaria non-endemic and endemic countries, the screening of blood donors for malaria is performed through interviewing ([@B18], [@B22]--[@B24]). Blood donation volunteers with a previous history of malaria or travels to, or residence in, malarious areas are deferred from blood donation permanently or for a certain period of time ([@B19]). The variety of deferral criteria is one of the most important factors that negatively impact blood availability ([@B20]). The method of blood donors screening is no different in endemic and non-endemic areas of Iran and it is carried out only through interviewing.

In the present study, the malaria-deferral rate was 0.18%, while other countries have reported different values. In Estonia 0.003%, France 0.1%--0.25%, Italy 0.1%--5%, Turkey 0.24%, Canada 0.4%, Spain 0.43%, Ireland 0.6% and the United States of America (USA) 0.75%--2.9% of blood donation volunteers were deferred for malaria risk ([@B9], [@B20], [@B29]). More than 90% of malaria-deferrals were because of travel to and residence in malaria endemic areas. Responsibility of blood donation volunteers to the issue of blood safety or their dishonesty in response to posed questions by the interviewer physician could explain the low deferral rate in this study.

The malaria-deferral rate is high in Sistan and Baluchistan (0.45%), Hormozgan (0.05%) and Kerman (0.17%) provinces as endemic areas and low in non-endemic provinces of Iran, but the highest malaria-deferral rates were observed in non-endemic provinces, including South Khorasan (0.82%), Razavi Khorasan (0.79%) and Yazd (0.54%) provinces. The higher rate might be explained by the precise and accurate implementation of donor selection and screening of blood donors in these provinces and the other non-endemic provinces such as Fars (0.32%), Bushehr (0.29%), Isfahan (0.28%) and Qazvin (0.22%) ([Table 1](#T1){ref-type="table"}) due to the proximity to Afghanistan, a country with high malaria endemicity ([@B2]), and endemic provinces of Iran ([Fig. 1](#F1){ref-type="fig"}). The low rate of malaria-deferral in endemic provinces showed that either the donor selection is not well done or the individuals do not donate blood because of the related trainings with blood donation eligibility criteria in malaria-endemic areas.

The results of this study indicated that 23,084 blood donation volunteers for malaria were deferred during the 5-year study period. This rate is negligible compared to the number of blood donors (*n*=10,167,915; 79.49%) and the malaria-deferral rate has no impact on blood availability in Iran. In the USA, more than 540,000 blood donations were lost due to malaria risk from 2000 to 2006 ([@B20]).

In several European countries, the serological testing of blood donation volunteers with a history of travel to, or residence in, malarious areas has reduced the unnecessary deferrals due to malaria risk and improved the safety of blood donations ([@B14], [@B17], [@B21], [@B30]--[@B33]). In Turkey, 97% of malaria-deferrals were unnecessary because the serological test detecting anti-*Plasmodium* antibodies were negative ([@B29]). The unnecessary deferrals dishearten the blood donation volunteers and many of them never return to donate blood ([@B34]).

In addition to the deferrals, a number of eligible volunteers do not donate blood for various reasons. Thus, the difference is observed between the total number of blood donation volunteers and the sum of blood donors and deferred volunteers, which in this study was 0.77%.

The age of more than 85% of temporarily malaria-deferred volunteers in this study was fewer than 46 yr. These individuals can donate blood for many years without worrying if the result of an immunological or molecular assay is negative after the deferral period. Therefore, the laboratory (parasitological, immunological and molecular) assays of temporarily malaria-deferred volunteers are necessary, done in countries such as France, England and Australia ([@B35]). In Iran, unfortunately, these volunteers are not investigated using laboratory assays after the deferral period.

In this study, more than 95% of malaria-deferred volunteers were male ([Table 1](#T1){ref-type="table"}). Since only 4.82% of Iranian blood donors were women during the 5-year study period, this could explain the much higher rate of malaria-deferrals in men.

Conclusion
==========

Given the prevalence of malaria in neighboring countries (Pakistan and Afghanistan) with high endemicity and several provinces of Iran ([@B2]) and the increasing human migration and movement between malaria non-endemic and endemic areas, the malaria-deferral rate should be higher than 0.18% in Iran. Therefore, the changing of donor selection process particularly in endemic areas for the prevention of TTM, the laboratory testing of the temporarily malaria-deferred volunteers after the deferral period and the precise and accurate implementation of donor selection must be considered. In addition, the usage of a serological test detecting anti-*Plasmodium* anti-bodies or a rapid diagnostic test (RDT) for antigen detection in combination with donor selection through interviewing is essential to prevent the occurrence of TTM and reduce unnecessary deferrals prior to deferral decision in malaria non-endemic and endemic areas of Iran, respectively.
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